Skip to main content
Medical information Clinical review pending

Transplant Testing

HLA DNA Typing High Resolution by Next Generation Sequencing (NGS) Test

HLA DNA Typing High Resolution by Next Generation Sequencing (NGS) is a crucial test for organ transplant compatibility. It identifies specific HLA markers to minimize the risk of organ rejection, improving transplant success rates.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (typically collected in an EDTA tube). Confirm specific requirements with the laboratory before booking.
Results
Confirm with the laboratory before booking.
Preparation
No special preparation is required for this test. However, confirm with the laboratory for any specific instructions.
Test priceKSh 31,590

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the HLA DNA Typing High Resolution by Next Generation Sequencing (NGS) Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Individuals preparing for a solid organ transplant
  • ✓Potential organ donors
  • ✓Patients with a history of organ transplant rejection
  • ✓Assessment of donor-recipient compatibility
  • ✓Guiding immunosuppressive therapy
  • ✓Research in transplantation immunology
02

In plain language

What this test helps you understand

This test is used to determine the compatibility between organ donors and recipients, aiming to minimize the risk of organ rejection and improve the success rate of solid organ transplantation.
The HLA DNA Typing High Resolution by Next Generation Sequencing (NGS) Test is a sophisticated diagnostic tool used to determine the compatibility between organ donors and recipients. This test is vital for solid organ transplantation, helping to identify specific Human Leukocyte Antigen (HLA) markers that influence the risk of organ rejection. Using advanced sequencing technology, this test provides high-resolution typing for more accurate matching.

This test measures key HLA markers, including HLA-A, HLA-B, HLA-C, HLA-DR, and HLA-DQ, at a high level of detail. These markers are proteins on cell surfaces that the immune system uses to distinguish self from non-self. Matching these markers between donor and recipient is critical for successful transplantation.

This test is recommended for individuals preparing for a solid organ transplant, potential organ donors, or those with a history of transplant rejection. Consultation with transplant specialists is advised to determine if this test is necessary based on your specific medical situation.

Benefits of this test include more accurate donor-recipient matching, increased likelihood of a successful transplant, reduced risk of post-operative complications from rejection, and support for personalized treatment strategies. Results indicate the specific HLA markers present in both donor and recipient. A close match is desirable to minimize rejection risk. Your healthcare team will interpret the results and guide further steps.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required for this test. However, confirm with the laboratory for any specific instructions.
SampleBlood sample (typically collected in an EDTA tube). Confirm specific requirements with the laboratory before booking.
MethodologyNext Generation Sequencing (NGS) is used to determine the HLA alleles at high resolution.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test identifies specific HLA alleles but does not predict all aspects of immune response or transplant rejection. Other factors, including non-HLA antibodies and overall patient health, also play a role in transplant success. Results are based on the provided sample and may be affected by sample quality.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

HLA (Human Leukocyte Antigen) typing identifies specific proteins on the surface of your cells that are crucial for the immune system. This test determines your unique HLA profile.
Matching HLA types between donor and recipient is critical for organ transplantation. A closer match reduces the risk of the recipient's immune system attacking the transplanted organ (rejection).
High-resolution typing provides a more detailed analysis of HLA markers compared to lower-resolution methods, leading to more accurate matching.
A blood sample is typically required for this test.
Turnaround time varies. Please confirm the current estimated time with the laboratory before booking.
Yes, a doctor's prescription on letterhead, along with photographs of both the recipient and donor, and the mandatory consent form for HLA Typing for Solid Organ Transplant (Form 33) are required.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp